An dieser Stelle finden Sie ausgewählte Publikationen aus der Nuklearmedizin

Hänscheid H, Kircher M, Schirbel A, Wunderlich G, Werner RA, Samnick S, Kotzerke J, Einsele H, Buck AK, Wester HJ, Grigoleit GU (2019)
Feasibility of CXCR4-Directed Radioligand Therapy in Advanced Diffuse Large B-Cell Lymphoma.
J Nucl Med 60:60-64.

Tran-Gia J, Lassmann M (2019)
Characterization of Noise and Resolution for Quantitative 177Lu SPECT/CT with xSPECT Quant.
J Nucl Med 60:50-59.

Werner RA, Wakabayashi H, Bauer J, Schütz C, Zechmeister C, Hayakawa N, Javadi MS, Lapa C, Jahns R, Ergün S, Jahns V, Higuchi T (2019)
Longitudinal 18F-FDG PET imaging in a rat model of autoimmune myocarditis.
Eur Heart J Cardiovasc Imaging 20:467-474.

Samnick S, Al-Momani E, Schmid JS, Mottok A, Buck AK, Lapa C (2018)
Initial Clinical Investigation of [18F]Tetrafluoroborate PET/CT in Comparison to [124I]Iodine PET/CT for Imaging Thyroid Cancer.
Clin Nucl Med 43:162-167.

Reich MM, Brumberg J, Pozzi NG, Marotta G, Roothans J, Åström M, Musacchio T, Lopiano L, Lanotte M, Lehrke R, Buck AK, Volkmann J, Isaias IU (2016)
Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy?
Brain 139:2948-2956.

Bluemel C, Cramer A, Grossmann C, Kajdi GW, Malzahn U, Lamp N, Langen HJ, Schmid J, Buck AK, Grimminger HJ, Herrmann K (2015)
iROLL: does 3-D radioguided occult lesion localization improve surgical management in early-stage breast cancer?
Eur J Nucl Med Mol Imaging 42:1692-1699.

Eberlein U, Scherthan H, Bluemel C, Peper M, Lapa C, Buck AK, Port M, Lassmann M (2015)
DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy.
J Nucl Med.57:173-179.

Herrmann K, Bluemel C, Weineisen M, Schottelius M, Wester HJ, Czernin J, Eberlein U, Beykan S, Lapa C, Riedmiller H, Krebs M, Kropf S, Schirbel A, Buck AK, Lassmann M (2015)
Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy.
J Nucl Med 56:855-861.

Philipp-Abbrederis K, Herrmann K, Knop S, Schottelius M, Eiber M, Lückerath K, Pietschmann E, Habringer S, Gerngroß C, Franke K, Rudelius M, Schirbel A, Lapa C, Schwamborn K, Steidle S, Hartmann E, Rosenwald A, Kropf S, Beer AJ, Peschel C, Einsele H, Buck AK, Schwaiger M, Götze K, Wester HJ, Keller U (2015)
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.
EMBO Mol Med 7:477-487.

Lapa C, Lückerath K, Malzahn U, Samnick S, Einsele H, Buck AK, Herrmann K, Knop S (2014)
18FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation.
Oncotarget 5:7381-7391

Publikationen 2018

Arnulfo G, Pozzi NG, Palmisano C, Leporini A, Canessa A, Brumberg J, Pezzoli G, Matthies C, Volkmann J, Isaias IU (2018)
Phase matters: A role for the subthalamic network during gait.
PLoS ONE 13(6).

Bauer WR, Lapa C, Reiter T (2018)
It's the Metabolism That Makes Macrophages Detectable in the Magnetic Resonance Scanner Immune Cell Detection by Hyperpolarized C-13 Magnetic Resonance Imaging.
Circ Res 122(8): 1039-1040.

Berninger M, Erk C, Fuss A, Skaf J, Al-Momani E, Israel I, Raschig M, Guentzel P, Samnick S, Holzgrabe U (2018)
Fluorine walk: The impact of fluorine in quinolone amides on their activity against African sleeping sickness.
Eur J Med Chem 152(): 377-391.

Beukhof CM, Massolt ET, Visser TJ, Korevaar TIM, Medici M, de Herder WW, van Lennep JER, Mulder MT, de Rijke YB, Reiners C, Verburg FA, Peeters RP (2018)
Effects of Thyrotropin on Peripheral Thyroid Hormone Metabolism and Serum Lipids.
Thyroid 28(2): 168-174.

Beykan S, Eberlein U, Werner RA, Lapa C, Buck AK, Kudlich T, Lassmann M (2018)
Patient-Specific Dosimetry of Lu-177-DOTATATE Peptide Receptor Radionuclide Therapy with High Activities.
Eur J Nucl Med Mol Imaging 45 1(): S33-S33 Typ=Meeting Abstract.

Brumberg J, Isaias IU (2018)
SPECT Molecular Imaging in Atypical Parkinsonism.
Int Rev Neurobiol 142(): 37-65.

Chen XY, Hirano M, Werner RA, Decker M, Higuchi T (2018)
Novel F-18-Labeled PET Imaging Agent FV45 Targeting the Renin-Angiotensin System.
ACS Omega 3(9): 10460-10470.

Chen XY, Werner RA, Lapa C, Nose N, Hirano M, Javadi MS, Robinson S, Higuchi T (2018)
Subcellular storage and release mode of the novel F-18-labeled sympathetic nerve PET tracer.
LMI1195 EJNMMI Res 8().

Cytawa W, Kircher S, Schirbel A, Shirai T, Fukushima K, Buck AK, Wester HJ, Lapa C (2018)
Chemokine Receptor 4 Expression in Primary Sjögren's Syndrome.
Clin Nucl Med 43(11): 835-836 Typ=Case Reports;Journal Article.

Da Via MC, Solimando AG, Garitano-Trojaola A, Barrio S, Rodhes N, Strifler S, Teufel E, Lapa C, Einsele H, Beilhack A, Kortuem KM (2018)
CIC-Mutation As a Potential Molecular Mechanism of Acquired Resistance to Combined BRAF/MEK Inhibition.
CNS Multiple Myeloma Blood 132(): Typ=Meeting Abstract.

Da Via MC, Trojaola AG, Solimando AG, Barrio SG, Teufel E, Einsele H, Lapa C, Beilhack A, Kortum MK (2018)
CIC-mutation as a potential molecular mechanism of acquired resistance to combined BRAF/MEK Inhibition.
CNS MM localization Oncology Research and Treatment 41 4(): 187-187 Typ=Meeting Abstract.

Duell J, Rosenwald A, Krummenast F, Buck A, Einsele H, Topp MS, Lapa C (2018)
CXCR4 PET/CT Scan Is Superior to FDG PET/CT Scan.
Accurately Defining Marginal Zone Lymphoma Nodal and Extranodal Blood 132(): Typ=Meeting Abstract.

Drozd VM, Branovan I, Shiglik N, Biko J, Reiners C (2018)
Thyroid Cancer Induction: Nitrates as Independent Risk Factors or Risk Modulators after Radiation Exposure, with a Focus on the Chernobyl Accident.
Eur Thyroid J 7(2): 67-74.

Flux GD, Gleisner KS, Chiesa C, Lassmann M, Chouin N, Gear J, Bardies M, Walrand S, Bacher K, Eberlein U, Ljungberg M, Strigari L, Visser E, Konijnenberg MW (2018)
From fixed activities to personalized treatments in radionuclide therapy: lost in translation?
Eur J Nucl Med Mol Imaging 45(1): 152-154.

Habringer S, Lapa C, Herhaus P, Schottelius M, Istvánffy R, Steiger K, Slotta-Huspenina J, Schirbel A, Hänscheid H, Kircher S, Buck AK, Götze K, Vick B, Jeremias I, Schwaiger M, Peschel C, Oostendorp R, Wester HJ, Grigoleit GU, Keller U (2018)
Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed Theranostics.
Theranostics 8(2): 369-383 Typ=Journal Article.

Hänscheid H, Lapa C, Buck AK, Lassmann M, Werner RA (2018)
Dose Mapping After Endoradiotherapy with Lu-DOTATATE/DOTATOC by a Single Measurement After 4 Days.
J Nucl Med 59(1): 75-81 Typ=Journal Article.

Heinze B, Fuss CT, Mulatero P, Beuschlein F, Reincke M, Mustafa M, Schirbel A, Deutschbein T, Williams TA, Rhayem Y, Quinkler M, Rayes N, Monticone S, Wild V, Gomez-Sanchez CE, Reis AC, Petersenn S, Wester HJ, Kropf S, Fassnacht M, Lang K, Herrmann K, Buck AK, Bluemel C, Hahner S (2018)
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.
Hypertension 71(2): 317-325 Typ=Journal Article.

Herhaus P, Maurer S, Lippenmayer R, Meys D, Schwaiger M, Buck A, Einsele H, Grigoleit GU, Keller U, Lapa C (2018)
Safety and toxicity of CXCR4-directed endoradiotherapy with Pentixather in hematologic malignancies: a retrospective analysis.
Oncology Research and Treatment 41 4(): 155-155 Typ=Meeting Abstract.

Israel I, Fluri F, Schadt F, Buck AK, Samnick S (2018)
Positron Emission Tomography and Autoradiography Imaging of P-selectin Activation Using Ga-68-Fucoidan in Photothrombotic Stroke Curr Neurovasc Res 15(1): 55-62.

Kertels O, Stolzenburg A, Mihovilovic M, Kessler A, Samnick S, Monoranu C, Löhr M, Buck A, Lapa C (2018)
[F-18]FET-PET/CT as a prognostic factor in newly-diagnosed gliomas II and III.
J Nucl Med 59(): Typ=Meeting Abstract.

Kircher M, Herhaus P, Schottelius M, Buck AK, Werner RA, Wester HJ, Keller U, Lapa C (2018)
CXCR4-directed theranostics in oncology and inflammation.
Ann Nucl Med 32(8): 503-511.

Lamparter D, Hallmann B, Haenscheid H, Boschi F, Malinconico M, Samnick S (2018)
Improved small scale production of iodine-124 for radiolabeling and clinical applications.
Appl Radiat Isot 140(): 24-28.

Lapa C, Kircher M, Hänscheid H, Schirbel A, Grigoleit GU, Klinker E, Böck M, Samnick S, Pelzer T, Buck AK (2018)
Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients.
Theranostics 8(3): 644-649 Typ=Journal Article;Research Support, Non-U.S. Gov't.

Lapa C, Schreder M, Lückerath K, Samnick S, Rudelius M, Buck AK, Kortüm KM, Einsele H, Rosenwald A, Knop S (2018)
[C]Methionine emerges as a new biomarker for tracking active myeloma lesions.
Br J Haematol 181(5): 701-703 Typ=Letter.

Lassmann M, Eberlein U (2018)
The Relevance of Dosimetry in Precision Medicine.
J Nucl Med 2018; 59(10): 1494-1499.

Lassmann M, Eberlein U (2018)
Targeted alpha-particle therapy: imaging, dosimetry, and radiation protection.
Ann ICRP 47(3-4): 187-195 Typ=Journal Article.

Leek F, Gregory R, Newbold K, Verburg FA, Luster M, Schurrat T, Lassmann M, Eberlein U, Buck AK, Lapa C, Bardies M, Mora-Ramirez E, Vallot D, Courbon F, Vija L, Flux G (2018)
The MEDIRAD Multi-national I-131 Dosimetry Study for Thyroid Ablation and Adjuvant Therapy
Eur J Nucl Med Mol Imaging 45(): S359-S360 Typ=Meeting Abstract.

Li X, Kemmer L, Zhang XL, Kircher M, Buck AK, Wester HJ, Hacker M, Lapa C (2018)
Anti-Inflammatory Effects on Atherosclerotic Lesions Induced by CXCR4-Directed Endoradiotherapy
J Am Coll Cardiol 72(1): 122-123.

Lisova K, Sergeev M, Evans-Axelsson S, Stuparu AD, Beykan S, Collins J, Jones J, Lassmann M, Herrmann K, Perrin D, Lee JT, Slavik R, van Dam RM (2018)
Microscale radiosynthesis, preclinical imaging and dosimetry study of [F-18]AMBF(3)-TATE: A potential PET tracer for clinical imaging of somatostatin receptors
Nucl Med Biol 61(): 36-44.

Machado JS, Tran-Gia J, Schloegl S, Buck A, Lassmann M (2018)
Biokinetics, dosimetry, and radiation risk in infants after Tc-99m-MAG3 scans
EJNMMI Res 8().

Marienhagen J, Brenner W, Buck A, Franzius C, Freudenberg LS, Gotthardt M, Lindner O, Mottaghy FM, Hellwig D (2018)
[Development of a national competency-based learning objective catalogue for undergraduate medical education in Germany].
Nuklearmedizin 57(4): 137-145 Typ=Journal Article.

Matsuura S, Katsumi H, Suzuki H, Hirai N, Hayashi H, Koshino K, Higuchi T, Yagi Y, Kimura H, Sakane T, Yamamoto A (2018)
L-Serine-modified polyamidoamine dendrimer as a highly potent renal targeting drug carrier
Proc Natl Acad Sci U S A 115(41): 10511-10516.

Meyerhof W, Voigt A, Huebner S, Lossow K, Toele J, Stolzenburg A, Brockhoff A, Blank K, Boehm U, Behrens M (2018)
The complex basis of bitterness perception Chem Senses 43(3): E2-E2 Typ=Meeting Abstract.

Neba J, Wuestemann J, Matthies P, Pinto F, Barthel T, Schwenkenbecher K, Grosser O, Lassmann M (2018)
Relevant Specific Simulation Parameters (ReSSiP) for validating the "true" device-simulated outcomes: A Handheld Gamma Camera System
Eur J Nucl Med Mol Imaging 45(): S781-S782 Typ=Meeting Abstract.

Nicolas GP, Beykan S, Bouterfa H, Kaufmann J, Bauman A, Lassmann M, Reubi JC, Rivier JEF, Maecke HR, Fani M, Wild D (2018)
Safety, Biodistribution, and Radiation Dosimetry of Ga-68-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
J Nucl Med 59(6): 909-914.

Nicolas G, Bodei L, Baum R, Herrmann K, Lassmann M, Hicks R, Navalkissoor S, Haug A, Oberwittler H, Wang T, Wild D (2018)
Phase 1/2 Open-Label Trial to Assess the Safety and Preliminary Efficacy of Lu-177-OPS201 as Peptide Receptor Radionuclide Therapy in Patients With Somatostatin Receptor-Positive, Progressive Neuroendocrine Tumors Pancreas 47(3): 349-349 Typ=Meeting Abstract.

Nose N, Werner RA, Ueda Y, Guenther K, Lapa C, Javadi MS, Fukushima K, Edenhofer F, Higuchi T (2018)
Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation: Functional assessment using in vitro radionuclide uptake assay
Int J Cardiol 269(): 229-234.

Palmisano C, Brandt G, Pozzi NG, Brumberg J, Leporini A, Marotta G, Cavallari P, Frigo CA, Pezzoli G, Isaias IU (2018)
Parkinsonism Relat Disord 46(): E76-E77 Typ=Meeting Abstract.

Reiter T, Kircher M, Schirbel A, Werner RA, Kropf S, Ertl G, Buck AK, Wester HJ, Bauer WR, Lapa C (2018)
Imaging of C-X-C Motif Chemokine Receptor CXCR4 Expression After Myocardial Infarction With [Ga-68] Pentixafor-PET/CT in Correlation With Cardiac MRI JACC Cardiovasc Imaging 11(10): 1541-1543.

Samnick S, Al-Momani E, Schmid JS, Mottok A, Buck AK, Lapa C (2018)
Initial Clinical Investigation of [18F]Tetrafluoroborate PET/CT in Comparison to [124I]Iodine PET/CT for Imaging Thyroid Cancer
Clin Nucl Med 43(3): 162-167.

Salas-Ramirez M, Tran-Gia J, Kesenheimer C, Weng AM, Kosmala A, Heidemeier A, Köstler H, Lassmann M (2018)
Quantification of fat fraction in lumbar vertebrae: correlation with age and implications for bone marrow dosimetry in molecular radiotherapy.
Phys Med Biol 63(2): 025029 Typ=Journal Article;Research Support, Non-U.S. Gov't.

Salas-Ramirez M, van Rietbergen B, Lassmann M (2018)
Prototype for a Mesh-based Radiation Transport Model for Bone Marrow Dosimetry using GATE
Eur J Nucl Med Mol Imaging 45(): S181-S182 Typ=Meeting Abstract.

Schumann S, Eberlein U, Mueller J, Lassmann M, Scherthan H (2018)
Absorbed dose-dependent DNA damage in leukocytes after internal irradiation of blood with Ra-224 compared to Ra-223
Eur J Nucl Med Mol Imaging 45(): S121-S122 Typ=Meeting Abstract.

Schumann S, Eberlein U, Muhtadi R, Lassmann M, Scherthan H (2018)
DNA damage in leukocytes after internal ex-vivo irradiation of blood with the alpha-emitter Ra-223
Sci Rep 8().

Schumann S, Eberlein U, Mueller J, Scherthan H, Lassmann M (2018)
Correlation of the absorbed dose to the blood and DNA damage in leukocytes after internal ex-vivo irradiation of blood samples with Ra-224
EJNMMI Res 8().

Selcuk NA, Toklu T, Beykan S, Karaaslan SI (2018)
Evaluation of the dosimetry approaches in ablation treatment of thyroid cancer
J. Appl. Clin. Med. Phys 19(4): 134-140.

Stolzenburg A, Lückerath K, Samnick S, Speer M, Kneer K, Schmid JS, Grigoleit GU, Hofmann S, Beer AJ, Bunjes D, Knop S, Buck AK, Einsele H, Lapa C (2018)
Prognostic value of [F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation.
Eur J Nucl Med Mol Imaging 45(10): 1694-1704 Typ=Journal Article.

Solimando AG, Da Via MC, Borrelli P, Leone P, Di Lernia G, Gaviria PT, Brandl A, Pedone GL, Rauert-Wunderlich H, Lapa C, Tafuri S, Bianchi FP, Ria R, Bittrich M, Ribatti D, Rosenwald A, Kortuem KM, Racanelli V, Vacca A, Einsele H, Beilhack A (2018)
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease
Blood 132(): Typ=Meeting Abstract.

Toele J, Stolzenburg A, Tyree SM, Staehler F, Meyerhof W (2018)
Tastant-Evoked Arc Expression in the Nucleus of the Solitary Tract and Nodose/Petrosal Ganglion of the Mouse Is Specific for Bitter Compounds
Chem Senses 43(4): 261-272.

Togawa K, Ahn HS, Auvinen A, Bauer AJ, Brito JP, Davies L, Kesminiene A, Laurier D, Ostroumova E, Pacini F, Reiners C, Shinkarev S, Thomas G, Tronko M, Vaccarella S, Schüz J (2018)
Long-term strategies for thyroid health monitoring after nuclear accidents: recommendations from an Expert Group convened by IARC Lancet Oncol 19(10): 1280-1283.

Tran-Gia J, Lassmann M (2018)
How Partial-Volume Effects Influence SPECT/CT-Based Organ Dose Estimates
Eur J Nucl Med Mol Imaging 45(): S182-S182 Typ=Meeting Abstract.

Tran-Gia J, Lassmann M (2018)
Optimizing Image Quantification for Lu-177 SPECT/CT Based on a 3D Printed 2-Compartment Kidney Phantom.
J Nucl Med 59(4): 616-624.

Tran-Gia J, Neumayer H, Lassmann M (2018)
On the Quantitative Accuracy of xSPECT Quant Based Renal Uptake Determination for Internal Dosimetry in Lu-177-PSMA Radioligand Therapy.
J Nucl Med 59(): Typ=Meeting Abstract.

Verburg FA, Gruenwald F, Lassmann M, Haenscheid H, Luster M, Dietlein M (2018)
Iodine-131 whole-body scintigraphy differentiated thyroid carcinoma.
Nuklearmedizin 57(4): 124-136.

Verburg FA, Giovanella L, Iakovou I, Konijnenberg MW, Langsteger W, Lassmann M, Mihailovic J, Luster M (2018)
I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?
Eur J Nucl Med Mol Imaging 45(13): 2247-2249.

Verburg FA, Mäder U, Giovanella L, Luster M, Reiners C (2018)
Low or Undetectable Basal Thyroglobulin Levels Obviate the Need for Neck Ultrasound in Differentiated Thyroid Cancer Patients After Total Thyroidectomy and I Ablation.
Thyroid 28(6): 722-728 Typ=Journal Article.

Verburg FA, Mäder U, Luster M, Reiners C (2018)
The effects of the Union for International Cancer Control/American Joint Committee on Cancer Tumour, Node, Metastasis system version 8 on staging of differentiated thyroid cancer: a comparison to version 7.
Clin Endocrinol (Oxf) 88(6): 950-956 Typ=Journal Article.

Wech T, Tran-Gia J, Rützel F, Klink T, Bley TA, Köstler H (2018)
Single-shot late Gd enhancement imaging of myocardial infarction with retrospectively adjustable contrast and heart-phase.
Magn Reson Imaging 47(): 48-53 Typ=Journal Article.

Werner RA, Andree C, Javadi MS, Lapa C, Buck AK, Higuchi T, Pomper MG, Gorin MA, Rowe SP, Pienta KJ (2018)
A Voice From the Past: Rediscovering the Virchow Node With Prostate-specific Membrane Antigen-targeted F-18-DCFPyL Positron Emission Tomography Imaging
Urology 117(): 18-21 Typ.

Werner RA, Bundschuh RA, Bundschuh L, Javadi MS, Higuchi T, Weich A, Sheikhbahaei S, Pienta KJ, Buck AK, Pomper MG, Gorin MA, Lapa C, Rowe SP (2018)
Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications.
Ann Nucl Med 32(8): 512-522 Typ=Journal Article;Review.

Werner RA, Bundschuh RA, Bundschuh L, Javadi MS, Leal JP, Higuchi T, Pienta KJ, Buck AK, Pomper MG, Gorin MA, Lapa C, Rowe SP (2018)
Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on F-18-DCFPyL PET/CT Imaging
J Nucl Med 59(12): 1857-1864.

Werner R, Bundschuh R, Higuchi T, Javadi M, Rowe S, Zsoter N, Buck A, Lapa C, Kreissl M (2018)
Volumetric Assessment Based On Baseline FDG PET Can Predict Survival In Medullary Thyroid Cancer Patients Scheduled For Vandetanib Treatment
Eur J Nucl Med Mol Imaging 45(): S49-S50 Typ=Meeting Abstract.

Werner R, Chen XY, Hirano M, Nose N, Lapa C, Javadi M, Higuchi T (2018)
The Impact of Ageing on [C-11]meta-Hydroxyephedrine Uptake in the Rat Heart
J Nucl Med 2018; 59().

Werner RA, Chen XY, Maya Y, Eissler C, Hirano M, Nose N, Wakabayashi H, Lapa C, Javadi MS, Higuchi T (2018)
The Impact of Ageing on 11C-Hydroxyephedrine Uptake in the Rat Heart Sci Rep 8().

Werner RA, Eissler C, Hayakawa N, Arias-Loza P, Wakabayashi H, Javadi MS, Chen XY, Shinaji T, Lapa C, Pelzer T, Higuchi T (2018)
Left Ventricular Diastolic Dysfunction in a Rat Model of Diabetic Cardiomyopathy using ECG-gated F-18-FDG PET Sci Rep 8().

Werner RA, Ilhan H, Lehner S, Papp L, Zsótér N, Schatka I, Muegge DO, Javadi MS, Higuchi T, Buck AK, Bartenstein P, Bengel F, Essler M, Lapa C, Bundschuh RA (2018)
Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy.
Mol Imaging Biol 20(6): 1068 Typ=Journal Article;PUBLISHED ERRATUM.

Werner RA, Kobayashi R, Javadi MS, Koeck Z, Wakabayashi H, Unterecker S, Nakajima K, Lapa C, Menke A, Higuchi T (2018)
Impact of Novel Antidepressants on Cardiac I-123-Metaiodobenzylguanidine Uptake: Experimental Studies on SK-N-SH Cells and Healthy Rabbits
J Nucl Med 59(7): 1099-1103.

Werner R, Marcus C, Sheikhbahaei S, Higuchi T, Solnes L, Rowe S, Buck A, Lapa C, Javadi M (2018)
The Impact of Ageing on Dopamine Transporter Imaging
J Nucl Med 59(): Typ=Meeting Abstract.

Werner R, Marcus C, Sheikhbahaei S, Higuchi T, Solnes L, Rowe S, Bucks A, Lapa C, Javadi M (2018)
Diagnostic Accuracy of Visual Assessment of an Initial DaT-Scan in Comparison to a Fully AutomaticSemiquantitative Method
J Nucl Med 59(): Typ=Meeting Abstract.

Werner RA, Schmid JS, Higuchi T, Javadi MS, Rowe SP, Märkl B, Aulmann C, Fassnacht M, Kroiss M, Reiners C, Buck AK, Kreissl M, Lapa C (2018)
Predictive Value of F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with Vandetanib.
J Nucl Med 59(5): 756-761 Typ=Journal Article.

Werner RA, Solnes LB, Javadi MS, Weich A, Gorin MA, Pienta KJ, Higuchi T, Buck AK, Pomper MG, Rowe SP, Lapa C (2018)
SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization Framework.
J Nucl Med 59(7): 1085-1091 Typ=Journal Article.

Werner RA, Wakabayashi H, Chen X, Hirano M, Shinaji T, Lapa C, Rowe SP, Javadi MS, Higuchi T (2018)
Functional Renal Imaging with 2-Deoxy-2-F-Fluorosorbitol PET in Rat Models of Renal Disorders.
J Nucl Med 59(5): 828-832 Typ=Journal Article.

Werner RA, Weich A, Kircher M, Solnes LB, Javadi MS, Higuchi T, Buck AK, Pomper MG, Rowe SP, Lapa C (2018)
The theranostic promise for Neuroendocrine Tumors in the late 2010s-Where do we stand, where do we go?
Theranostics 8(22): 6088-6100.

Wevrett J, Fenwick A, Scuffham J, Johansson L, Gear J, Schlögl S, Segbers M, Sjögreen-Gleisner K, Solny P, Lassmann M, Tipping J, Nisbet A (2018)
Inter-comparison of quantitative imaging of lutetium-177 (Lu-177) in European hospitals EJNMMI Phys 5().

Wieder H, Beer AJ, Siveke J, Schuster T, Buck AK, Herrmann K, Stollfuss JC (2018)
18F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancer.
Oncotarget 9(11): 10128-10134 Typ=Journal Article.

Wöckel A, Festl J, Stüber T, Brust K, Krockenberger M, Heuschmann PU, Jírů-Hillmann S, Albert US, Budach W, Follmann M, Janni W, Kopp I, Kreienberg R, Kühn T, Langer T, Nothacker M, Scharl A, Schreer I, Link H, Engel J, Fehm T, Weis J, Welt A, Steckelberg A, Feyer P, König K, Hahne A, Baumgartner T, Kreipe HH, Knoefel WT, Denkinger M,
Brucker S, Lüftner D, Kubisch C, Gerlach C, Lebeau A, Siedentopf F, Petersen C, Bartsch HH, Schulz-Wendtland R, Hahn M, Hanf V, Müller-Schimpfle M, Henscher U, Roncarati R, Katalinic A, Heitmann C, Honegger C, Paradies K, Bjelic-Radisic V, Degenhardt F, Wenz F, Rick O, Hölzel D, Zaiss M, Kemper G, Budach V, Denkert C, Gerber B, Tesch H, Hirsmüller S, Sinn HP, Dunst J, Münstedt K, Bick U, Fallenberg E, Tholen R, Hung R, Baumann F, Beckmann MW, Blohmer J, Fasching P, Lux MP, Harbeck N, Hadji P, Hauner H, Heywang-Köbrunner S, Huober J, Hübner J, Jackisch C, Loibl S, Lück HJ, von Minckwitz G, Möbus V, Müller V, Nöthlings U, Schmidt M, Schmutzler R, Schneeweiss A, Schütz F, Stickeler E, Thomssen C, Untch M, Wesselmann S, Bücker A, Buck A, Stangl S (2018)
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer.
Geburtsh Frauenheilk 78(11): 1056-1088 Typ=Journal Article.

Wuestemann J, Pinto FA, Mesri M, Matthies P, Neba JC, Pech M, Kreissl MC, Lassmann M, Grosser OS (2018)
Interventional Real-Time Quantification of Y-90-Microspheres Distribution in Selective Internal Radiotherapy
Eur J Nucl Med Mol Imaging 45(): S167-S168 Typ=Meeting Abstract.

Xu L, Tetteh G, Lipkova J, Zhao Y, Li HW, Christ P, Piraud M, Buck A, Shi KY, Menze BH (2018)
Automated Whole-Body Bone Lesion Detection for Multiple Myeloma on Ga-68-Pentixafor PET/CT Imaging Using Deep Learning Methods Contrast Media Mol Imaging.

Publikationen 2017

Al-Momani E, Israel I, Samnick S (2017)
Validation of a [AlF]PSMA-11 preparation for clinical applications.
Appl Radiat Isot. 130: 102-108 (Impact(2016)=1.128, Typ=Journal Article).

Barquero R, Garcia HP, Incio MG, Minguez P, Cardenas A, Martínez D, Lassmann M (2017)
I activity quantification of gamma camera planar images.
Phys Med Biol. 62(3): 909-926 (Impact(2016)=2.742, Typ=Journal Article; Research Support, Non-U.S. Gov't).

Barrio MJ, Spick C, Radu CG, Lassmann M, Eberlein U, Allen-Auerbach M, Schiepers C, Slavik R, Czernin J, Herrmann K (2017)
Human Biodistribution and Radiation Dosimetry of F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage Pathway.
J Nucl Med. 58(3): 374-378 (Impact(2016)=6.646, Typ=Journal Article).

Bieber M, Werner RA, Tanai E, Hofmann U, Higuchi T, Schuh K, Heuschmann PU, Frantz S, Ritter O, Kraft P, Kleinschnitz C (2017)
Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted F-DCFPyL in peripheral ganglia.
Ann Nucl Med. 31(9): 696-702 (Impact(2016)=1.396, Typ=Journal Article).

Bluemel C, Hahner S, Heinze B, Fassnacht M, Kroiss M, Bley TA, Wester HJ, Kropf S, Lapa C, Schirbel A, Buck AK, Herrmann K (2017)
Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients.
Clin Nucl Med. 42(1): e29-e34 (Impact(2016)=3.64, Typ=Article; Journal Article).

Bowles H, Sánchez N, Tapias A, Paredes P, Campos F, Bluemel C, Valdés Olmos RA, Vidal-Sicart S (2017)
Radioguided surgery and the GOSTT concept: From pre-operative image and intraoperative navigation to image-assisted excision. Rev Esp Med Nucl Imagen Mol. 36(3): 175-184 (Impact: liegt nicht vor, Typ=Journal Article).

Brumberg J, Küsters S, Al-Momani E, Marotta G, Cosgrove KP, van Dyck CH, Herrmann K, Homola GA, Pezzoli G, Buck AK, Volkmann J, Samnick S, Isaias IU (2017)
Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study.
Ann Clin Transl Neurol. 4(9): 632-639 (Impact: liegt nicht vor, Typ=Article; Journal Article).

Buck AK, Stolzenburg A, Hänscheid H, Schirbel A, Lückerath K, Schottelius M, Wester HJ, Lapa C (2017)
Chemokine receptor - Directed imaging and therapy.
Methods. 2017;130: 63-71 (Impact(2016)=3.802, Typ=Journal Article; Review).

Chiesa C, Sjogreen Gleisner K, Flux G, Gear J, Walrand S, Bacher K, Eberlein U, Visser EP, Chouin N, Ljungberg M, Bardiès M, Lassmann M, Strigari L, Konijnenberg MW (2017)
The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy.
Eur J Nucl Med Mol Imaging. 44(11): 1783-1786 (Impact(2016)=7.277, Typ=Editorial).

Doppler K, Jentschke HM, Schulmeyer L, Vadasz D, Janzen A, Luster M, Höffken H, Mayer G, Brumberg J, Booij J, Musacchio T, Klebe S, Sittig-Wiegand E, Volkmann J, Sommer C, Oertel WH (2017)
Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
Acta Neuropathol (Berl). 133(4): 535-545 (Impact(2016)=12.213, Typ=Journal Article).

Eberlein U, Cremonesi M, Lassmann M (2017)
Individualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?
J Nucl Med. 58(Suppl 2): 97S-103S (Impact(2016)=6.646, Typ=Journal Article; Review)

Fendler WP, Barrio M, Spick C, Allen-Auerbach M, Ambrosini V, Benz M, Bluemel C, Grewal RK, Lapa C, Miederer M, Nicolas G, Schuster T, Czernin J, Herrmann K (2017)
Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study.
J Nucl Med. 58(10): 1617-1623 (Impact(2016)=6.646, Typ=Journal Article; Clinical Trial; Multicenter Study).

Flux GD, Verburg FA, Chiesa C, Bardiès M, Gleisner KS, Hertz B, Konijnenberg M, Lassmann M, Ljungberg M, Luster M, Stabin M, Strigari L (2017)
Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details. J Nucl Med. 58(5): 862 (Impact(2016)=6.646, Typ=Letter).

Hayakawa N, Yamane T, Arias-Loza AP, Shinaji T, Wakabayashi H, Lapa C, Werner RA, Javadi MS, Pelzer T, Higuchi T (2017)
Impact of tissue photon attenuation in small animal cardiac PET imaging.
Int J Cardiol. 227: 257-260 (Impact(2016)=6.189, Typ=Journal Article).

Hänscheid H, Lapa C, Buck AK, Lassmann M, Werner RA (2017)
Absorbed dose estimates from a single measurement one to three days after the administration of 177Lu-DOTATATE/-TOC.
Nuklearmedizin. 56(6): 219-224 (Impact(2016)=1.087, Typ=Journal Article).

Kesner AL, Poli GL, Beykan S, Lassmann M (2017)
The IAEA Radiotracer Biodistribution Template - A community resource for supporting the standardization and reporting of radionuclide pre-dosimetry data.
Phys Med. 44: 83-85 (Impact(2016)=1.99, Typ=Journal Article).

Kircher M, Lapa C (2017)
Novel Noninvasive Nuclear Medicine Imaging Techniques for Cardiac Inflammation.
Curr Cardiovasc Imaging Rep. 10(2): 6 (Impact: liegt nicht vor, Typ=Journal Article; Review).

Kobayashi R, Chen X, Werner RA, Lapa C, Javadi MS, Higuchi T (2017)
New horizons in cardiac innervation imaging: introduction of novel F-labeled PET tracers.
Eur J Nucl Med Mol Imaging. 44(13): 2302-2309 (Impact(2016)=7.277, Typ=Journal Article).

Lapa C, Arias-Loza P, Hayakawa N, Wakabayashi H, Werner RA, Chen X, Shinaji T, Herrmann K, Pelzer T, Higuchi T (2017)
Whitening and Impaired Glucose Utilization of Brown Adipose Tissue in a Rat Model of Type 2 Diabetes Mellitus.
Sci Rep. 7(1): 16795 (Impact(2016)=4.259, Typ=Journal Article).

Lapa C, Garcia-Velloso MJ, Lückerath K, Samnick S, Schreder M, Otero PR, Schmid JS, Herrmann K, Knop S, Buck AK, Einsele H, San-Miguel J, Kortüm KM (2017)
(11)C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different Institutions.
Theranostics. 7(11): 2956-2964 (Impact(2016)=8.712, Typ=Article; Journal Article).

Lapa C, Herrmann K, Schirbel A, Hänscheid H, Lückerath K, Schottelius M, Kircher M, Werner RA, Schreder M, Samnick S, Kropf S, Knop S, Buck AK, Einsele H, Wester HJ, Kortüm KM (2017)
CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma.
Theranostics. 7(6): 1589-1597 (Impact(2016)=8.712, Typ=Article; Journal Article).

Lapa C, Kircher S, Schirbel A, Rosenwald A, Kropf S, Pelzer T, Walles T, Buck AK, Weber WA, Wester HJ, Herrmann K, Lückerath K (2017)
Targeting CXCR4 with [Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma?
Oncotarget. 8(57): 96732-96737 (Impact(2016)=5.168, Typ=Journal Article).

Lapa C, Schirbel A, Samnick S, Lückerath K, Kortüm KM, Knop S, Wester HJ, Buck AK, Schreder M (2017)
The gross picture: intraindividual tumour heterogeneity in a patient with nonsecretory multiple myeloma.
Eur J Nucl Med Mol Imaging. 44(6): 1097-1098 (Impact(2016)=7.277, Typ=Editorial Material; Journal Article).

Lapa C, Schreder M, Schirbel A, Samnick S, Kortüm KM, Herrmann K, Kropf S, Einsele H, Buck AK, Wester HJ, Knop S, Lückerath K (2017)
[(68)Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [(18)F]FDG and laboratory values.
Theranostics. 7(1): 205-212 (Impact(2016)=8.712, Typ=Article; Journal Article).

Luster M, Pfestroff A, Hänscheid H, Verburg FA (2017)
Radioiodine Therapy.
Semin Nucl Med. 47(2): 126-134 (Impact: liegt nicht vor, Typ=Journal Article; Review).

Reich MM, Pozzi NG, Brumberg J, Åström M, Volkmann J, Isaias IU (2017)
Brain. 140(5): e28 (Impact(2016)=10.292, Typ=Journal Article).

Schottelius M, Osl T, Poschenrieder A, Hoffmann F, Beykan S, Hänscheid H, Schirbel A, Buck AK, Kropf S, Schwaiger M, Keller U, Lassmann M, Wester HJ (2017)
[Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent.
Theranostics. 7(9): 2350-2362 (Impact(2016)=8.712, Typ=Journal Article).

Schwarzenboeck SM, Rauscher I, Bluemel C, Fendler WP, Rowe SP, Pomper MG, Asfhar-Oromieh A, Herrmann K, Eiber M (2017)
PSMA Ligands for PET Imaging of Prostate Cancer.
J Nucl Med. 58(10): 1545-1552 (Impact(2016)=6.646, Typ=Journal Article; Review).

Segerer FJ, Biko J, Reiners C, Wirth C, Hebestreit H (2017)
Exercise-Induced Hypoxemia in Juvenile Thyroid Carcinoma With Lung Metastases.
Pediatr Exerc Sci. 29(3): 361-370 (Impact(2016)=1.704, Typ=Article; Journal Article).

Sheikhbahaei S, Jones CS, Porter KK, Rowe SP, Gorin MA, Baras AS, Pierorazio PM, Ball MW, Higuchi T, Johnson PT, Solnes LB, Epstein JI, Allaf ME, Javadi MS (2017)
Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses.
Clin Nucl Med. 42(4): e188-e193 (Impact(2016)=3.64, Typ=Journal Article; Evaluation Studies).

Verburg FA, Hänscheid H, Luster M (2017)
Radioactive iodine (RAI) therapy for metastatic differentiated thyroid cancer.
Best Pract Res Clin Endocrinol Metab. 31(3): 279-290 (Impact(2016)=4.466, Typ=Journal Article; Review).

Verburg FA, Luster M, Giovanella L, Lassmann M, Chiesa C, Chouin N, Flux G, EANM Thyroid, Radiation Protection and Dosimetry Committees (2017)
The "reset button" revisited: why high activity I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients.
Eur J Nucl Med Mol Imaging. 44(6): 915-917 (Impact(2016)=7.277, Typ=Comment; Editorial).

Verburg FA, Mäder U, Grelle I, Giovanella L, Reiners C, Hänscheid H (2017)
Only a Rapid Complete Biochemical Remission After 131I-Therapy is Associated with an Unimpaired Life Expectancy in Differentiated Thyroid Cancer.
Horm Metab Res. 49(11): 860-868 (Impact(2016)=2.268, Typ=Journal Article).

Walenkamp AME, Lapa C, Herrmann K, Wester HJ (2017)
CXCR4 Ligands: The Next Big Hit?
J Nucl Med. 58(Suppl 2): 77S-82S (Impact(2016)=6.646, Typ=Journal Article; Review).

Werner RA, Lapa C, Ilhan H, Higuchi T, Buck AK, Lehner S, Bartenstein P, Bengel F, Schatka I, Muegge DO, Papp L, Zsótér N, Große-Ophoff T, Essler M, Bundschuh RA (2017)
Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity.
Oncotarget. 8(4): 7039-7049 (Impact(2016)=5.168, Typ=Journal Article; Clinical Trial; Multicenter Study).

Werner R, Weich A, Higuchi T, Schmid J, Schirbel A, Lassmann M, Wild V, Rudelius M, Kudlich T, Herrmann K, Scheurlen M, Buck A, Kropf S, Wester HJ, Lapa C (2017)
Triple Tracer Imaging Approach for the Non-Invasive Assessment of Chemokine Receptor 4 Expression in Gastroenteropancreatic Neuroendocrine Tumors Neuroendocrinology. 105 1: 176-176 (Impact(2016)=3.608, Typ=Meeting Abstract).

Werner RA, Weich A, Higuchi T, Schmid JS, Schirbel A, Lassmann M, Wild V, Rudelius M, Kudlich T, Herrmann K, Scheurlen M, Buck AK, Kropf S, Wester HJ, Lapa C (2017)
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach. Theranostics. 7(6): 1489-1498 (Impact(2016)=8.712, Typ=Article; Journal Article).

Werner RA, Weich A, Schirbel A, Samnick S, Buck AK, Higuchi T, Wester HJ, Lapa C (2017)
Intraindividual tumor heterogeneity in NET - Further insight by C-X-C motif chemokine receptor 4-directed imaging.
Eur J Nucl Med Mol Imaging. 44(3): 553-554 (Impact(2016)=7.277, Typ=Editorial Material; Case Reports; Journal Article).

Wiyaporn K, Tocharoenchai C, Pusuwan P, Higuchi T, Fung GSK, Feng T, Park MJ, Tsui BMW (2017)
Optimization of imaging protocols for myocardial blood flow (MBF) quantification with F-flurpiridaz PET.
Phys Med. 42: 127-134 (Impact(2016)=1.99, Typ=Journal Article).

Zimmerman BE, Gro?ev D, Buvat I, Coca Pérez MA, Frey EC, Green A, Krisanachinda A, Lassmann M, Ljungberg M, Pozzo L, Quadir KA, Terán Gretter MA, Van Staden J, Poli GL (2017)
Multi-centre evaluation of accuracy and reproducibility of planar and SPECT image quantification: An IAEA phantom study.
Z Med Phys. 27(2): 98-112 (Impact(2016)=1.531, Typ=Journal Article; Multicenter Study).

Publikationen 2016

Beykan S, Dam JS, Eberlein U, Kaufmann J, Kjærgaard B, Jødal L, Bouterfa H, Bejot R, Lassmann M, Jensen SB (2016)
(177)Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model.
EJNMMI Res 6(1):50.

Bluemel C, Kirchner P, Kajdi GW, Werner RA, Herrmann K (2016)
Localization of Parathyroid Adenoma With Real-Time Ultrasound: Freehand SPECT Fusion.
Clin Nucl Med 41(3):e141-2.

Bluemel C, Krebs M, Polat B, Linke F, Eiber M, Samnick S, Lapa C, Lassmann M, Riedmiller H, Czernin J, Rubello D, Bley T, Kropf S, Wester HJ, Buck AK, Herrmann K (2016)
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT.
Clin Nucl Med 41(7):515-21.

Bluemel C, Linke F, Herrmann K, Simunovic I, Eiber M, Kestler C, Buck AK, Schirbel A, Bley TA, Wester HJ, Vergho D, Becker A (2016)
Impact of (68)Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy.
EJNMMI Res 6(1):78.

Bluemel C, Matthies P, Herrmann K, Povoski SP (2016)
3D scintigraphic imaging and navigation in radioguided surgery: freehand SPECT technology and its clinical applications.
Expert Rev Med Devices 13(4):339-51.

Bluemel C, Safak G, Cramer A, Wöckel A, Gesierich A, Hartmann E, Schmid JS, Kaiser F, Buck AK, Herrmann K (2016)
Fusion of freehand SPECT and ultrasound: First experience in preoperative localization of sentinel lymph nodes.
Eur J Nucl Med Mol Imaging 43(13):2304-2312.

Boschi S, Lee JT, Beykan S, Slavik R, Wei L, Spick C, Eberlein U, Buck AK, Lodi F, Cicoria G, Czernin J, Lassmann M, Fanti S, Herrmann K (2016)
Synthesis and preclinical evaluation of an Al(18)F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand.
Eur J Nucl Med Mol Imaging 43(12):2122-2130.

Buck A, Decristoforo C (2016)
Highlights lecture EANM 2015: the search for nuclear medicine's superheroes.
Eur J Nucl Med Mol Imaging 43(10):1910-27.

Canessa A, Pozzi NG, Arnulfo G, Brumberg J, Reich MM, Pezzoli G, Ghilardi MF, Matthies C, Steigerwald F, Volkmann J, Isaias IU (2016)
Striatal Dopaminergic Innervation Regulates Subthalamic Beta-Oscillations and Cortical-Subcortical Coupling during Movements: Preliminary Evidence in Subjects with Parkinson's Disease.
Front Hum Neurosci 10:611.

Carr Z, Clarke M, Akl EA, Schneider R, Murith C, Li C, Parrish-Sprowl J, Stenke L, Cui-Ping L, Bertrand S, Miller C (2016)
Using the Grade Approach to Support the Development of Recommendations for Public Health Interventions in Radiation Emergencies.
Radiat Prot Dosimetry 171(1):144-55.

de Galiza Barbosa F, Delso G, Ter Voert EE, Huellner MW, Herrmann K, Veit-Haibach P (2016)
Multi-technique hybrid imaging in PET/CT and PET/MR: what does the future hold?
Clin Radiol 71(7):660-72.

Dietlein M, Eschner W, Grünwald F, Lassmann M, Verburg FA, Luster M (2016)
Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4.
Nuklearmedizin 55(3):77-89.

Dietlein M, Grünwald F, Schmidt M, Schneider P, Verburg FA, Luster M (2016)
Radioiodine therapy for benign thyroid diseases (version 5).
German Guideline. Nuklearmedizin 55(6):213-220.

Düwel C, Blümel C, Westenfelder K, Wagner-Thiessen E, Becker A, Gschwend JE, Eiber M, Maurer T (2016)
Rectal mucosa metastasis in recurrent prostate cancer : (68)Ga-PSMA-PET/CT allows targeted salvage radiotherapy.
Urologe A 55(8):1086-8.

Eberlein U, Scherthan H, Bluemel C, Peper M, Lapa C, Buck AK, Port M, Lassmann M (2016)
DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy.
J Nucl Med 57(2):173-9.

Fahey FH, Bom HH, Chiti A, Choi YY, Huang G, Lassmann M, Laurin N, Mut F, Nuñez-Miller R, O'Keeffe D, Pradhan P, Scott AM, Song S, Soni N, Uchiyama M, Vargas L (2016)
Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 2-Current Standards and the Path Toward Global Standardization.
J Nucl Med 57(7):1148-57.

Fanti S, Minozzi S, Castellucci P, Balduzzi S, Herrmann K, Krause BJ, Oyen W, Chiti A (2016)
PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.
Eur J Nucl Med Mol Imaging 43(1):55-69.

Fecher D, Hofmann E, Buck A, Bundschuh R, Nietzer S, Dandekar G, Walles T, Walles H, Lückerath K, Steinke M (2016)
Human Organotypic Lung Tumor Models: Suitable For Preclinical 18F-FDG PET-Imaging.
PLoS ONE 11(8):e0160282.

Heckl S, Reiners C, Buck AK, Schäfer A, Dick A, Scheurlen M (2016)
Evidence of impaired carbohydrate assimilation in euthyroid patients with Hashimoto's thyroiditis.
Eur J Clin Nutr 70(2):222-8.

Herrmann K, Schottelius M, Lapa C, Osl T, Poschenrieder A, Hänscheid H, Lückerath K, Schreder M, Bluemel C, Knott M, Keller U, Schirbel A, Samnick S, Lassmann M, Kropf S, Buck AK, Einsele H, Wester HJ, Knop S (2016)
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease.
J Nucl Med 57(2):248-51.

Israel I, Ohsiek A, Al-Momani E, Albert-Weissenberger C, Stetter C, Mencl S, Buck AK, Kleinschnitz C, Samnick S, Sirén AL (2016)
Combined [(18)F]DPA-714 micro-positron emission tomography and autoradiography imaging of microglia activation after closed head injury in mice.
J Neuroinflammation 13(1):140.

Jakob F, Genest F, Seefried L, Tsourdi E, Lapa C, Hofbauer LC (2016)
Diagnostics in osteology].
Internist (Berl) 57(7):631-7

Kestler C, Weng AM, Kunz AS, Laubmeier M, Wirth C, Köstler H, Bley TA, Veldhoen S (2016)
Acute Pulmonary Artery Embolism Detected by Noncontrast Functional Lung Magnetic Resonance Imaging.
Circ Cardiovasc Imaging 9(2):e004141.

Kroiss M, Plonné D, Kendl S, Schirmer D, Ronchi CL, Schirbel A, Zink M, Lapa C, Klinker H, Fassnacht M, Heinz W, Sbiera S (2016)
Association of mitotane with chylomicrons and serum lipoproteins: practical implications for treatment of adrenocortical carcinoma.
Eur J Endocrinol 174(3):343-53.

Lapa C, Hänscheid H, Wild V, Pelzer T, Schirbel A, Werner RA, Droll S, Herrmann K, Buck AK, Lückerath K (2016)
Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy.
Oncotarget 7(15):20033-40.

Lapa C, Knop S, Schreder M, Rudelius M, Knott M, Jörg G, Samnick S, Herrmann K, Buck AK, Einsele H, Lückerath K (2016)
(11)C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement.
Theranostics 6(2):254-61.

Lapa C, Lückerath K, Kleinlein I, Monoranu CM, Linsenmann T, Kessler AF, Rudelius M, Kropf S, Buck AK, Ernestus RI, Wester HJ, Löhr M, Herrmann K (2016)
(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.
Theranostics 6(3):428-34.

Lapa C, Lückerath K, Rudelius M, Schmid JS, Schoene A, Schirbel A, Samnick S, Pelzer T, Buck AK, Kropf S, Wester HJ, Herrmann K (2016)
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experience.
Oncotarget 7(8):9288-95.

Lapa C, Reiter T, Kircher M, Schirbel A, Werner RA, Pelzer T, Pizarro C, Skowasch D, Thomas L, Schlesinger-Irsch U, Thomas D, Bundschuh RA, Bauer WR, Gärtner FC (2016)
Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI.
Oncotarget 7(47):77807-77814.

Lapa C, Werner RA, Herrmann K (2016)
Visualization of tumor heterogeneity in neuroendocrine tumors by positron emission tomography.
Endocrine 51(3):556-7.

Ljungberg M, Celler A, Konijnenberg MW, Eckerman KF, Dewaraja YK, Sjögreen-Gleisner K, SNMMI MIRD Committee , Bolch WE, Brill AB, Fahey F, Fisher DR, Hobbs R, Howell RW, Meredith RF, Sgouros G, Zanzonico P, EANM Dosimetry Committee , Bacher K, Chiesa C, Flux G, Lassmann M, Strigari L, Walrand S (2016)
MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy.
J Nucl Med 57(1):151-62.

Machado JS, Beykan S, Herrmann K, Lassmann M (2016)
Recommended administered activities for (68)Ga-labelled peptides in paediatric nuclear medicine.
Eur J Nucl Med Mol Imaging 43(11):2036-9.

Maya Y, Werner RA, Schütz C, Wakabayashi H, Samnick S, Lapa C, Zechmeister C, Jahns R, Jahns V, Higuchi T (2016)
11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis.
J Nucl Med 57(12):1985-1990.

Nose N, Fukushima K, Lapa C, Werner RA, Javadi MS, Taki J, Higuchi T (2016)
Assessment of coronary flow reserve using a combination of planar first-pass angiography and myocardial SPECT: Comparison with myocardial (15)O-water PET.
Int J Cardiol 222:209-12.

Othman EM, Oli RG, Arias-Loza PA, Kreissl MC, Stopper H (2016)
Metformin Protects Kidney Cells From Insulin-Mediated Genotoxicity In Vitro and in Male Zucker Diabetic Fatty Rats.
Endocrinology 157(2):548-59.

Rasche L, Menoret E, Dubljevic V, Menu E, Vanderkerken K, Lapa C, Steinbrunn T, Chatterjee M, Knop S, Düll J, Greenwood DL, Hensel F, Rosenwald A, Einsele H, Brändlein S (2016)
A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement.
Clin Cancer Res 22(17):4341-9.

Reich MM, Brumberg J, Pozzi NG, Marotta G, Roothans J, Åström M, Musacchio T, Lopiano L, Lanotte M, Lehrke R, Buck AK, Volkmann J, Isaias IU (2016)
Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy?
Brain 139(11):2948-2956.

Reiners C, Schneider R, Akashi M, Akl EA, Jourdain JR, Li C, Murith C, Van Bladel L, Yamashita S, Zeeb H, Vitti P, Carr Z (2016)
The First Meeting of the WHO Guideline Development Group for the Revision of the WHO 1999 Guidelines for Iodine Thyroid Blocking.
Radiat Prot Dosimetry 171(1):47-56.

Sawatzky E, Al-Momani E, Kobayashi R, Higuchi T, Samnick S, Decker M (2016)
A Novel Way To Radiolabel Human Butyrylcholinesterase for Positron Emission Tomography through Irreversible Transfer of the Radiolabeled Moiety.
ChemMedChem 11(14):1540-50.

Scheidt HA, Haralampiev I, Theisgen S, Schirbel A, Sbiera S, Huster D, Kroiss M, Müller P (2016)
The adrenal specific toxicant mitotane directly interacts with lipid membranes and alters membrane properties depending on lipid composition.
Mol Cell Endocrinol 428:68-81.

Schmid JS, Schirbel A, Buck AK, Kropf S, Wester HJ, Lapa C (2016)
[68Ga]Pentixafor-Positron Emission Tomography/Computed Tomography Detects Chemokine Receptor CXCR4 Expression After Ischemic Stroke.
Circ Cardiovasc Imaging 9(9):e005217.

Sigurdson AJ, Brenner AV, Roach JA, Goudeva L, Müller JA, Nerlich K, Reiners C, Schwab R, Pfeiffer L, Waldenberger M, Braganza M, Xu L, Sturgis EM, Yeager M, Chanock SJ, Pfeiffer RM, Abend M, Port M (2016)
Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.
Carcinogenesis 37(7):677-684.

Spick C, Herrmann K, Czernin J (2016)
18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients.
J Nucl Med 57(3):420-30.

Tran-Gia J, Bisdas S, Köstler H, Klose U (2016)
A model-based reconstruction technique for fast dynamic T1 mapping.
Magn Reson Imaging 34(3):298-307.

Tran-Gia J, Lohr D, Weng AM, Ritter CO, Stäb D, Bley TA, Köstler H (2016)
A model-based reconstruction technique for quantitative myocardial perfusion imaging. Magn Reson Med 76(3):880-7.

Tran-Gia J, Schlögl S, Lassmann M (2016)
Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology.
J Nucl Med 57(12):1998-2005.

Valls L, Badve C, Avril S, Herrmann K, Faulhaber P, O'Donnell J, Avril N (2016)
FDG-PET imaging in hematological malignancies.
Blood Rev 30(4):317-31.

Vrachimis A, Riemann B, Mäder U, Reiners C, Verburg FA (2016)
Endogenous TSH levels at the time ofI ablation do not influence ablation success, recurrence-free survival or differentiated thyroid cancer-related mortality. Eur J Nucl Med Mol Imaging 43(2):224-231.

Wakabayashi H, Werner RA, Hayakawa N, Javadi MS, Xinyu C, Herrmann K, Rowe SP, Lapa C, Higuchi T (2016)
Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging Agent. J Nucl Med 57(10):1625-1628.

Werner RA, Beykan S, Higuchi T, Lückerath K, Weich A, Scheurlen M, Bluemel C, Herrmann K, Buck AK, Lassmann M, Lapa C, Hänscheid H (2016)
The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathy.
Oncotarget 7(27):41233-41241.

Werner RA, Kroiss M, Nakajo M, Mügge DO, Hahner S, Fassnacht M, Schirbel A, Bluemel C, Higuchi T, Papp L, Zsótér N, Buck AK, Bundschuh RA, Lapa C (2016)
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.
Endocrine 53(3):791-800.

Werner RA, Lückerath K, Schmid JS, Higuchi T, Kreissl MC, Grelle I, Reiners C, Buck AK, Lapa C (2016)
Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment - initial experience.
Sci Rep 6:28081.

Werner RA, Maya Y, Rischpler C, Javadi MS, Fukushima K, Lapa C, Herrmann K, Higuchi T (2016)
Sympathetic nerve damage and restoration after ischemia-reperfusion injury as assessed by (11)C-hydroxyephedrine.
Eur J Nucl Med Mol Imaging 43(2):312-8.

Publikationen 2015

Al-Momani E, Israel I, Buck AK, Samnick S (2015)
Improved synthesis of [¹⁸F]FS-PTAD as a new tyrosine-specific prosthetic group for radiofluorination of biomolecules.
Appl Radiat Isot 104:136-42.

Baur J, Schedelbeck U, Pulzer A, Bluemel C, Wild V, Fassnacht M, Steger U (2015)
A case report of a solitary pancreatic metastasis of an adrenocortical carcinoma.
BMC Surg 15:93.

Bluemel C, Cramer A, Grossmann C, Kajdi GW, Malzahn U, Lamp N, Langen HJ, Schmid J, Buck AK, Grimminger HJ, Herrmann K (2015)
iROLL: does 3-D radioguided occult lesion localization improve surgical management in early-stage breast cancer?
Eur J Nucl Med Mol Imaging 42(11):1692-9.

Bluemel C, Herrmann K, Giammarile F, Nieweg OE, Dubreuil J, Testori A, Audisio RA, Zoras O, Lassmann M, Chakera AH, Uren R, Chondrogiannis S, Colletti PM, Rubello D (2015)
EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.
Eur J Nucl Med Mol Imaging 42(11):1750-66.

Bluemel C, Rubello D, Colletti PM, de Bree R, Herrmann K (2015)
Sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma: current status and unresolved challenges.
Eur J Nucl Med Mol Imaging 42(9):1469-80.

Chen X, Werner RA, Javadi MS, Maya Y, Decker M, Lapa C, Herrmann K, Higuchi T (2015)
Radionuclide imaging of neurohormonal system of the heart.
Theranostics 5(6)545-58.

Drozd VM, Saenko VA, Brenner AV, Drozdovitch V, Pashkevich VI, Kudelsky AV, Demidchik YE, Branovan I, Shiglik N, Rogounovitch TI, Yamashita S, Biko J, Reiners C (2015)
Major Factors Affecting Incidence of Childhood Thyroid Cancer in Belarus after the Chernobyl Accident: Do Nitrates in Drinking Water Play a Role?
PLoS ONE(10):9-e0137226.

Eberlein U, Nowak C, Bluemel C, Buck AK, Werner RA, Scherthan H, Lassmann M (2015)
DNA damage in blood lymphocytes in patients after (177)Lu peptide receptor radionuclide therapy.
Eur J Nucl Med Mol Imaging 42(11):1739-49.

Eberlein U, Peper M, Fernández M, Lassmann M, Scherthan H (2015)
Calibration of the ?-H2AX DNA double strand break focus assay for internal radiation exposure of blood lymphocytes.
PLoS ONE(10):4-e0123174.

Fahey FH, Bom HH, Chiti A, Choi YY, Huang G, Lassmann M, Laurin N, Mut F, Nuñez-Miller R, O'Keeffe D, Pradhan P, Scott AM, Song S, Soni N, Uchiyama M, Vargas L (2015)
Standardization of administered activities in pediatric nuclear medicine: a report of the first nuclear medicine global initiative project, part 1-statement of the issue and a review of available resources.
J Nucl Med 56(4):646-51.

Fendler WP, Chalkidis RP, Ilhan H, Knösel T, Herrmann K, Issels RD, Bartenstein P, Cyran CC, Lindner LH, Hacker M (2015)
Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence.
Eur Radiol 25(8):2214-21.

Fendler WP, Lehmann M, Todica A, Herrmann K, Knösel T, Angele MK, Dürr HR, Rauch J, Bartenstein P, Cyran CC, Hacker M, Lindner LH (2015)
PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma.
J Nucl Med 56(4):530-7.

Fluri F, Grünstein D, Cam E, Ungethuem U, Hatz F, Schäfer J, Samnick S, Israel I, Kleinschnitz C, Orts-Gil G, Moch H, Zeis T, Schaeren-Wiemers N, Seeberger P (2015)
Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral inflammation after ischemic stroke in normotensive and hypertensive rats.
Exp Neurol 265:142-51.

Foryst-Ludwig A, Kreissl MC, Benz V, Brix S, Smeir E, Ban Z, Januszewicz E, Salatzki J, Grune J, Schwanstecher AK, Blumrich A, Schirbel A, Klopfleisch R, Rothe M, Blume K, Halle M, Wolfarth B, Kershaw EE, Kintscher U (2015)
Adipose Tissue Lipolysis Promotes Exercise-induced Cardiac Hypertrophy Involving the Lipokine C16:1n7-Palmitoleate. J Biol Chem 290(39):23603-15.

Hänscheid H, Fernández M, Lassmann M (2015)
The absorbed dose to blood from blood-borne activity.
Phys Med Biol 60(2):741-53.

Herrmann K, Bluemel C, Weineisen M, Schottelius M, Wester HJ, Czernin J, Eberlein U, Beykan S, Lapa C, Riedmiller H, Krebs M, Kropf S, Schirbel A, Buck AK, Lassmann M (2015)
Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy.
J Nucl Med 56(6)855-61.

Herrmann K, Czernin J, Wolin EM, Gupta P, Barrio M, Gutierrez A, Schiepers C, Mosessian S, Phelps ME, Allen-Auerbach MS (2015)
Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspective.
J Nucl Med 56(1):70-5.

Herrmann K, Lapa C, Wester HJ, Schottelius M, Schiepers C, Eberlein U, Bluemel C, Keller U, Knop S, Kropf S, Schirbel A, Buck AK, Lassmann M (2015)
Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor.
J Nucl Med 56(3):410-6.

Herrmann K, Queiroz M, Huellner MW, de Galiza Barbosa F, Buck A, Schaefer N, Stolzman P, Veit-Haibach P (2015)
Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT.
BMC Cancer 15:1002.

Kläsner B, Buchmann N, Gempt J, Ringel F, Lapa C, Krause BJ (2015)
Early [18F]FET-PET in Gliomas after Surgical Resection: Comparison with MRI and Histopathology.
PLoS ONE(10):10-e0141153.

Kletting P, Schimmel S, Hänscheid H, Luster M, Fernández M, Nosske D, Lassmann M, Glatting G (2015)
The NUKDOS software for treatment planning in molecular radiotherapy.
Z Med Phys 25(3):264-74.

Kreissl MC, Fassnacht M, Mueller SP (2015)
Systemic treatment of advanced differentiated and medullary thyroid cancer.
Overview and practical aspects. Nuklearmedizin 54(3):88-93.

Lapa C, Linsenmann T, Lückerath K, Samnick S, Herrmann K, Stoffer C, Ernestus RI, Buck AK, Löhr M, Monoranu CM (2015)
Tumor-associated macrophages in glioblastoma multiforme-a suitable target for somatostatin receptor-based imaging and therapy?
PLoS ONE(10):3-e0122269.

Lapa C, Maya Y, Wagner M, Arias-Loza P, Werner RA, Herrmann K, Higuchi T (2015)
Activation of brown adipose tissue in hypothyroidism.
Ann Med 47(7):538-45.

Lapa C, Reiter T, Li X, Werner RA, Samnick S, Jahns R, Buck AK, Ertl G, Bauer WR (2015)
Imaging of myocardial inflammation with somatostatin receptor based PET/CT - A comparison to cardiac MRI.
Int J Cardiol 194:44-9.

Lapa C, Werner RA, Schmid JS, Papp L, Zsótér N, Biko J, Reiners C, Herrmann K, Buck AK, Bundschuh RA (2015)
Prognostic value of positron emission tomography-assessed tumor heterogeneity in patients with thyroid cancer undergoing treatment with radiopeptide therapy.
Nucl Med Biol 42(4)349-54.

Leonova TA, Drozd VM, Saenko VA, Mine M, Biko J, Rogounovitch TI, Takamura N, Reiners C, Yamashita S (2015)
Bone mineral density in treated at a young age for differentiated thyroid cancer after Chernobyl female patients on TSH-suppressive therapy receiving or not Calcium-D3 supplementation.
Endocr J 62(2):173-82.

Linz C, Müller-Richter UD, Buck AK, Mottok A, Ritter C, Schneider P, Metzen D, Heuschmann P, Malzahn U, Kübler AC, Herrmann K, Bluemel C (2015)
Performance of cone beam computed tomography in comparison to conventional imaging techniques for the detection of bone invasion in oral cancer.
Int J Oral Maxillofac Surg 44(1):8-15.

Lorenz R, Buck A, Reiners C (2015)
In-patient nuclear medicine therapy in Germany from 2010 to 2012. Analysis of structured quality reports.
Nuklearmedizin 54(2):61-8.

Lückerath K, Lapa C, Albert C, Herrmann K, Jörg G, Samnick S, Einsele H, Knop S, Buck AK (2015)
11C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma.
Oncotarget 6(10):8418-29.

Macedo R, Javadi SM, Higuchi T, Carvalho MD, Medeiros Vde F, Azevedo ÍM, Lima FP, Medeiros AC (2015)
Heart and systemic effects of statin pretreatment in a rat model of abdominal sepsis. Assessment by Tc99m-sestamibi biodistribition.
Acta Cir Bras 30(6):388-93.

Maffione AM, Lopci E, Bluemel C, Giammarile F, Herrmann K, Rubello D (2015)
Diagnostic accuracy and impact on management of (18)F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review.
Eur J Nucl Med Mol Imaging 42(1):152-63.

Pacilio M, Amato E, Lanconelli N, Basile C, Torres LA, Botta F, Ferrari M, Diaz NC, Perez MC, Fernández M, Lassmann M, Gil AV, Cremonesi M (2015)
Differences in 3D dose distributions due to calculation method of voxel S-values and the influence of image blurring in SPECT.
Phys Med Biol 60(5):1945-64.

Paschke R, Lincke T, Müller SP, Kreissl MC, Dralle H, Fassnacht M (2015)
The Treatment of Well-Differentiated Thyroid Carcinoma.
Dtsch Arztebl Int 112(26):452-8.

Philipp-Abbrederis K, Herrmann K, Knop S, Schottelius M, Eiber M, Lückerath K, Pietschmann E, Habringer S, Gerngroß C, Franke K, Rudelius M, Schirbel A, Lapa C, Schwamborn K, Steidle S, Hartmann E, Rosenwald A, Kropf S, Beer AJ, Peschel C, Einsele H, Buck AK, Schwaiger M, Götze K, Wester HJ, Keller U (2015)
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.
EMBO Mol Med 7(4):477-87.

Porschen R, Buck A, Fischbach W, Gockel I, Görling U, Grenacher L, Hollerbach S, Hölscher A, Körber J, Messmann H, Meyer HJ, Miehlke S, Möhler M, Nöthlings U, Pech U, Schmidberger H, Schmidt M, Stahl M, Stuschke M, Thuss-Patience P, Trojan J, Vanhoefer U, Weimann A, Wenz F, Wullstein C (2015)
S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus.
Z Gastroenterol 53(11):1288-347.

Reiter T, Werner RA, Bauer WR, Lapa C (2015)
Detection of cardiac sarcoidosis by macrophage-directed somatostatin receptor 2-based positron emission tomography/computed tomography.
Eur Heart J 36(35):2404.

Rowe SP, Gorin MA, Gordetsky J, Ball MW, Pierorazio PM, Higuchi T, Epstein JI, Allaf ME, Javadi MS (2015)
Initial experience using 99mTc-MIBI SPECT/CT for the differentiation of oncocytoma from renal cell carcinoma.
Clin Nucl Med 40(4):309-13.

Sbiera S, Leich E, Liebisch G, Sbiera I, Schirbel A, Wiemer L, Matysik S, Eckhardt C, Gardill F, Gehl A, Kendl S, Weigand I, Bala M, Ronchi CL, Deutschbein T, Schmitz G, Rosenwald A, Allolio B, Fassnacht M, Kroiss M (2015)
Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells.
Endocrinology 156(11):3895-908.

Schmidt T, Lordick F, Herrmann K, Ott K (2015)
Value of functional imaging by PET in esophageal cancer.
J Natl Compr Canc Netw 13(2)239-47.

Thomas L, Lapa C, Bundschuh RA, Polat B, Sonke JJ, Guckenberger M (2015)
Tumour delineation in oesophageal cancer - A prospective study of delineation in PET and CT with and without endoscopically placed clip markers.
Radiother Oncol 116(2)269-75.

Tillmanns J, Schneider M, Fraccarollo D, Schmitto JD, Länger F, Richter D, Bauersachs J, Samnick S (2015)
PET imaging of cardiac wound healing using a novel [68Ga]-labeled NGR probe in rat myocardial infarction.
Mol Imaging Biol 17(1)76-86.

Verburg FA, Mäder U, Luster M, Hänscheid H, Reiners C (2015)
Determinants of successful ablation and complete remission after total thyroidectomy and ¹³¹I therapy of paediatric differentiated thyroid cancer.
Eur J Nucl Med Mol Imaging 42(9):1390-8.

Weineisen M, Schottelius M, Simecek J, Baum RP, Yildiz A, Beykan S, Kulkarni HR, Lassmann M, Klette I, Eiber M, Schwaiger M, Wester HJ (2015)
68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.
J Nucl Med 56(8):1169-76.

Werner RA, Bluemel C, Allen-Auerbach MS, Higuchi T, Herrmann K (2015)
68Gallium- and 90Yttrium-/ 177Lutetium: "theranostic twins" for diagnosis and treatment of NETs.
Ann Nucl Med 29(1):1-7.

Werner RA, Bluemel C, Lassmann M, Kudlich T, Higuchi T, Lopci E, Allen-Auerbach M, Colletti PM, Rubello D, Zatelli MC, Herrmann K (2015)
SPECT- and PET-based patient-tailored treatment in neuroendocrine tumors: a comprehensive multidisciplinary team approach.
Clin Nucl Med 40(5):e271-7.

Werner RA, Brumberg J, Dierks A, Herrmann K, Biko J, Buck AK, Lapa C (2015)
Paralytic subileus as an adverse effect of amino acid-based nephroprotection in a patient undergoing peptide receptor radionuclide therapy.
Clin Nucl Med 40(3):263-4.

Werner RA, Rischpler C, Onthank D, Lapa C, Robinson S, Samnick S, Javadi M, Schwaiger M, Nekolla SG, Higuchi T (2015)
Retention Kinetics of the 18F-Labeled Sympathetic Nerve PET Tracer LMI1195: Comparison with 11C-Hydroxyephedrine and 123I-MIBG.
J Nucl Med 56(9):1429-33.

Werner RA, Schmid JS, Muegge DO, Lückerath K, Higuchi T, Hänscheid H, Grelle I, Reiners C, Herrmann K, Buck AK, Lapa C (2015)
Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment.
Medicine (Baltimore) 94(45):e2016.

Wester HJ, Keller U, Schottelius M, Beer A, Philipp-Abbrederis K, Hoffmann F, Šimeek J, Gerngross C, Lassmann M, Herrmann K, Pellegata N, Rudelius M, Kessler H, Schwaiger M (2015)
Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging.
Theranostics 5(6):618-30.

Publikationen 2014

Bluemel C, Herrmann K, Kübler A, Buck AK, Geissinger E, Wild V, Hartmann S, Lapa C, Linz C, Müller-Richter U (2014)
Intraoperative 3-D imaging improves sentinel lymph node biopsy in oral cancer.
Eur J Nucl Med Mol Imaging 41(12):2257-64.

Bluemel C, Herrmann K, Müller-Richter U, Lapa C, Higuchi T, Wild V, Buck AK, Kübler A, Linz C (2014)
Freehand SPECT-guided sentinel lymph node biopsy in early oral squamous cell carcinoma.
Head Neck 36(11):E112-6.

Buder K, Lapa C, Kreissl MC, Schirbel A, Herrmann K, Schnack A, Bröcker EB, Goebeler M, Buck AK, Becker JC (2014)
Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging.
BMC Cancer 14:268

Bundschuh RA, Dinges J, Neumann L, Seyfried M, Zsótér N, Papp L, Rosenberg R, Becker K, Astner ST, Henninger M, Herrmann K, Ziegler SI, Schwaiger M, Essler M (2014)
Textural Parameters of Tumor Heterogeneity in ¹?F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer.
J Nucl Med 55(6):891-7.

Ceci F, Herrmann K, Castellucci P, Graziani T, Bluemel C, Schiavina R, Vollmer C, Droll S, Brunocilla E, Mazzarotto R, Buck AK, Fanti S (2014)
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial.
Eur J Nucl Med Mol Imaging 41(12):2222-31.

Chen DY, Schneider PF, Zhang XS, Luo XY, He ZM, Chen T (2014)
Changes in graves' ophthalmopathy after radioiodine and anti-thyroid drug treatment of Graves' disease from 2 prospective, randomized, open-label, blinded end point studies.
Exp Clin Endocrinol Diabetes 122(1):1-6.

Graf N, Li Z, Herrmann K, Weh D, Aichler M, Slawska J, Walch A, Peschel C, Schwaiger M, Buck AK, Dechow T, Keller U (2014)
Positron emission tomographic monitoring of dual phosphatidylinositol-3-kinase and mTOR inhibition in anaplastic large cell lymphoma.
Onco Targets Ther 7:789-98.

Hänscheid H, Fernández M, Eberlein U, Lassmann M (2014)
Self-irradiation of the blood from selected nuclides in nuclear medicine.
Phys Med Biol 59(6):1515-31.

Hänscheid H, Lassmann M, Buck AK, Reiners C, Verburg FA (2014)
The limit of detection in scintigraphic imaging with I-131 in patients with differentiated thyroid carcinoma.
Phys Med Biol 59(10):2353-68.

Heger U, Bader F, Lordick F, Burian M, Langer R, Dobritz M, Blank S, Bruckner T, Becker K, Herrmann K, Siewert JR, Ott K (2014)
Interim endoscopy results during neoadjuvant therapy for gastric cancer correlate with histopathological response and prognosis.
Gastric Cancer 17(3):478-88.

Herrmann K, Buck AK, Schuster T, Abbrederis K, Blümel C, Santi I, Rudelius M, Wester HJ, Peschel C, Schwaiger M, Dechow T, Keller U (2014)
Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL.
Oncotarget 5(12):4050-9.

Herrmann K, Czernin J, Cloughesy T, Lai A, Pomykala KL, Benz MR, Buck AK, Phelps ME, Chen W. (2014) Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients. Neuro-oncol 16(4):603-9.

Isaias IU, Spiegel J, Brumberg J, Cosgrove KP, Marotta G, Oishi N, Higuchi T, Küsters S, Schiller M, Dillmann U, van Dyck CH, Buck A, Herrmann K, Schloegl S, Volkmann J, Lassmann M, Fassbender K, Lorenz R, Samnick S (2014)
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease.
Front Aging Neurosci 6:13.

Israel I, Richter D, Stritzker J, van Ooschot M, Donat U, Buck AK, Samnick S (2014)
PET imaging with [⁶⁸Ga]NOTA-RGD for prostate cancer: a comparative study with [¹⁸F]fluorodeoxyglucose and [¹⁸F]fluoroethylcholine.
Curr Cancer Drug Targets 14(4):371-9.

Karantanis D, Kalkanis D, Czernin J, Herrmann K, Pomykala KL, Bogsrud TV, Subramaniam RM, Lowe VJ, Allen-Auerbach MS (2014)
Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: a survey of referring physicians.
J Nucl Med 55(12):1925-9.

Krohn T, Hänscheid H, Müller B, Behrendt FF, Heinzel A, Mottaghy FM, Verburg FA (2014)
Maximum dose rate is a determinant of hypothyroidism after 131I therapy of Graves' disease but the total thyroid absorbed dose is not.
J Clin Endocrinol Metab    99(11):4109-15.

Lapa C, Linsenmann T, Monoranu CM, Samnick S, Buck AK, Bluemel C, Czernin J, Kessler AF, Homola GA, Ernestus RI, Löhr M, Herrmann K (2014)
Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
J Nucl Med 55(10):1611-6.

Lapa C, Linz C, Bluemel C, Mottok A, Mueller-Richter U, Kuebler A, Schneider P, Czernin J, Buck AK, Herrmann K (2014)
Three-phase bone scintigraphy for imaging osteoradionecrosis of the jaw.
Clin Nucl Med 39(1):21-5.

Lapa C, Lückerath K, Malzahn U, Samnick S, Einsele H, Buck AK, Herrmann K, Knop S (2014)
18 FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation.
Oncotarget 5(17):7381-91.

Lassmann M, Treves ST, EANM/SNMMI Paediatric Dosage Harmonization Working Group , Boellaard R, Bolch W, Borgwardt L, Chiti A, Fahey F, Gelfand M, Lassmann M, Parisi M, Pfluger T, Spottswood S, Treves ST (2014)
Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines.
Eur J Nucl Med Mol Imaging 41(5):1036-41.

Li X, Bauer W, Israel I, Kreissl MC, Weirather J, Richter D, Bauer E, Herold V, Jakob P, Buck A, Frantz S, Samnick S (2014)
Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI.
Arterioscler Thromb Vasc Biol 34(8):1661-7.

Lorenz R, Samnick S, Dillmann U, Schiller M, Ong MF, Faßbender K, Buck A, Spiegel J (2014)
Nicotinic α4β2 acetylcholine receptors and cognitive function in Parkinson's disease.
Acta Neurol Scand 130(3):164-71.

Mencacci NE, Isaias IU, Reich MM, Ganos C, Plagnol V, Polke JM, Bras J, Hersheson J, Stamelou M, Pittman AM, Noyce AJ, Mok KY, Opladen T, Kunstmann E, Hodecker S, Münchau A, Volkmann J, Samnick S, Sidle K, Nanji T, Sweeney MG, Houlden H, Batla A, Zecchinelli AL, Pezzoli G, Marotta G, Lees A, Alegria P, Krack P, Cormier-Dequaire F, Lesage S, Brice A, Heutink P, Gasser T, Lubbe SJ, Morris HR, Taba P, Koks S, Majounie E, Raphael Gibbs J, Singleton A, Hardy J, Klebe S, Bhatia KP, Wood NW, International Parkinson's Disease Genomics Consortium and UCL-exomes consortium (2014)
Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.
Brain 137(Pt 9):2480-92.

Ott K, Schmidt T, Lordick F, Herrmann K (2014)
Importance of PET in surgery of esophageal cancer.
Chirurg 85(6):505-12.

Richter D, Basse-Lüsebrink TC, Kampf T, Fischer A, Israel I, Schneider M, Jakob PM, Samnick S (2014)
Compressed sensing for reduction of noise and artefacts in direct PET image reconstruction.
Z Med Phys 24(1):16-26.

Schneider PF, Biko J, Varazashvili L, Neumann S (2014)
β-Radiation exposure to fingertips after using a trained routine application method during radiosynovectomy.
Nucl Med Commun 35(11):1175-8.

Strigari L, Konijnenberg M, Chiesa C, Bardies M, Du Y, Gleisner KS, Lassmann M, Flux G (2014)
The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy.
Eur J Nucl Med Mol Imaging 41(10):1976-88.

Sweeney R, Polat B, Samnick S, Reiners C, Flentje M, Verburg FA (2014)
O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy.
Ann Nucl Med 28(2)154-62.

Thies ED, Tanase K, Maeder U, Luster M, Buck AK, Hänscheid H, Reiners C, Verburg FA (2014)
The number of 131I therapy courses needed to achieve complete remission is an indicator of prognosis in patients with differentiated thyroid carcinoma.
Eur J Nucl Med Mol Imaging 41(12):2281-90.

Verburg FA, Mäder U, Grelle I, Visser TJ, Peeters RP, Smit JW, Reiners C (2014)
The thyroid axis 'setpoints' are significantly altered after long-term suppressive LT4 therapy.
Horm Metab Res 46(11):794-9.

Verburg FA, Mäder U, Reiners C, Hänscheid H (2014)
Long-term survival in differentiated thyroid cancer is worse after low-activity initial post-surgical 131I therapy in both high- and low-risk patients.
J Clin Endocrinol Metab 99(12):4487-96.

Werner RA, Bluemel C, Lapa C, Muegge DO, Kudlich T, Buck AK, Herrmann K (2014)
Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?
Nucl Med Commun 35(11):1143-9.

Wieder HA, Pomykala KL, Benz MR, Buck AK, Herrmann K (2014)
PET tracers in musculoskeletal disease beyond FDG.
Semin Musculoskelet Radiol 18(2):123-32.

Wiegering A, Herrmann K, Bluemel C, Buck AK, Germer CT (2014)
Importance of FDG-PET/CT for surgery of rectal cancer.
Chirurg 85(6):487-92.

Wurmb T, Kühne CA, Schneider R (2014)
In-hospitaltraumamanagement - radiation emergency and multiple trauma - principals of treatment in the emergency room.
Anasthesiol Intensivmed Notfallmed Schmerzther 49(9):556-9.

Yamane T, Park MJ, Richter D, Nekolla SG, Javadi MS, Lapa C, Samnick S, Buck AK, Herrmann K, Higuchi T (2014)
Small-animal PET imaging of isolated perfused rat heart.
J Nucl Med 55(3):495-9.

Publikationen 2013

Al-Ibraheem A, Buck AK, Benz MR, Rudert M, Beer AJ, Mansour A, Pomykala KL, Haller B, Juenger H, Scheidhauer K, Schwaiger M, Herrmann K (2013)
(18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
Cancer 119(6):1227-34.

Berger ML, Hammerschmidt F, Qian R, Hahner S, Schirbel A, Stichelberger M, Schibli R, Yu J, Arion VB, Woschek A, Öhler E, Zolle IM (2013)
[(3)H]metyrapol and 4-[(131)i]iodometomidate label overlapping, but not identical, binding sites on rat adrenal membranes.
Mol Pharm 10(3):1119-30.

Bluemel C, Lapa C, Mottok A, Hahner S, Herrmann K (2013)
Tumor localization in ectopic Cushing syndrome using combined PET/CT imaging.
Clin Nucl Med 38 (9):749-51.

Bluemel C, Schnelzer A, Okur A, Ehlerding A, Paepke S, Scheidhauer K, Kiechle M (2013)
Freehand SPECT for image-guided sentinel lymph node biopsy in breast cancer.

Bundschuh RA, Wendl CM, Weirich G, Eiber M, Souvatzoglou M, Treiber U, Kübler H, Maurer T, Gschwend JE, Geinitz H, Grosu AL, Ziegler SI, Krause BJ (2013)
Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimens.
Eur J Nucl Med Mol Imaging 40(7):1126-34.

Del Guerra A, Bardies M, Belcari N, Caruana CJ, Christofides S, Erba P, Gori C, Lassmann M, Lonsdale MN, Sattler B, Waddington W (2013)
Curriculum for education and training of medical physicists in nuclear medicine: recommendations from the EANM Physics Committee, the EANM Dosimetry Committee and EFOMP.
Phys Med 29(2):139-62.

Dießl S, Verburg F, Biko J, Schryen B, Reiners C, Buck A, Hänscheid H (2013)
Improved follow-up of patients with differentiated thyroid carcinoma. The quantitative detection limit of 131I uptake in diagnostic scans.
Nuklearmedizin 52(3):81-7.

Dörr JR, Yu Y, Milanovic M, Beuster G, Zasada C, Däbritz JH, Lisec J, Lenze D, Gerhardt A, Schleicher K, Kratzat S, Purfürst B, Walenta S, Mueller-Klieser W, Gräler M, Hummel M, Keller U, Buck AK, Dörken B, Willmitzer L, Reimann M, Kempa S, Lee S, Schmitt CA (2013)
Synthetic lethal metabolic targeting of cellular senescence in cancer therapy.
Nature 501(7467):421-5.

Eberlein U, Lassmann M (2013)
Dosimetry of [⁶⁸Ga]-labeled compounds.
Appl Radiat Isot 76:70-4.

Elisei R, Schlumberger MJ, Müller SP, Schöffski P, Brose MS, Shah MH, Licitra L, Jarzab B, Medvedev V, Kreissl MC, Niederle B, Cohen EE, Wirth LJ, Ali H, Hessel C, Yaron Y, Ball D, Nelkin B, Sherman SI (2013)
Cabozantinib in progressive medullary thyroid cancer.
J Clin Oncol 31(29):3639-46.

Essler M, Wantke J, Mayer B, Scheidhauer K, Bundschuh RA, Haller B, Astner ST, Molls M, Andratschke N (2013)
Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapy.
Strahlenther Onkol 189(6):495-501.

Eur J Nucl Med Mol Imaging 40(11):1656-61.

Fernández M, Hänscheid H, Mauxion T, Bardiès M, Kletting P, Glatting G, Lassmann M (2013)
A fast method for rescaling voxel S values for arbitrary voxel sizes in targeted radionuclide therapy from a single Monte Carlo calculation.
Med Phys 40(8):082502.

Frank-Raue K, Machens A, Leidig-Bruckner G, Rondot S, Haag C, Schulze E, Lorenz A, Kreissl MC, Dralle H, Raue F, Schmid KW (2013)
Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma.
Thyroid 23 (3):294-300.

Glatting G, Bardiès M, Lassmann M (2013)
Treatment planning in molecular radiotherapy.
Z Med Phys 23(4):262-9.

Graf N, Herrmann K, Numberger B, Zwisler D, Aichler M, Feuchtinger A, Schuster T, Wester HJ, Senekowitsch-Schmidtke R, Peschel C, Schwaiger M, Keller U, Dechow T, Buck AK (2013)
[18F]FLT is superior to [18F]FDG for predicting early response to antiproliferative treatment in high-grade lymphoma in a dose-dependent manner.

Grande E, Kreissl MC, Filetti S, Newbold K, Reinisch W, Robert C, Schlumberger M, Tolstrup LK, Zamorano JL, Capdevila J (2013)
Vandetanib in advanced medullary thyroid cancer: review of adverse event management strategies.
Adv Ther 

Hahner S, Kreissl MC, Fassnacht M, Haenscheid H, Bock S, Verburg FA, Knoedler P, Lang K, Reiners C, Buck AK, Allolio B, Schirbel A
Functional characterization of adrenal lesions using [123I]IMTO-SPECT/CT.

J Clin Endocrinol Metab 98(4):1508-18.

Hänscheid H, Canzi C, Eschner W, Flux G, Luster M, Strigari L, Lassmann M (2013)
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II.
Dosimetry prior to radioiodine therapy of benign thyroid diseases.

Herrmann K, Dahlbom M, Nathanson D, Wei L, Radu C, Chatziioannou A, Czernin J. (2013)
Evaluation of the Genisys4, a bench-top preclinical PET scanner.
J Nucl Med   

Higuchi T, Yousefi BH, Kaiser F, Gärtner F, Rischpler C, Reder S, Yu M, Robinson S, Schwaiger M, Nekolla SG (2013)
Assessment of the 18F-labeled PET tracer LMI1195 for imaging norepinephrine handling in rat hearts.
J Nucl Med 54(7):1142-6.

Horm Metab Res 45(10):728-35.

Is the image quality of I-124-PET impaired by an automatic correction of prompt gammas? PLoS ONE 8(8):e71729.

Jurowich CF, Rikkala PR, Thalheimer A, Wichelmann C, Seyfried F, Sander V, Kreissl M, Germer CT, Koepsell H, Otto C (2013)
Duodenal-jejunal bypass improves glycemia and decreases SGLT1-mediated glucose absorption in rats with streptozotocin-induced type 2 diabetes.
Ann Surg 258(1):89-97.

Kletting P, Schimmel S, Kestler HA, Hänscheid H, Luster M, Fernández M, Bröer JH, Nosske D, Lassmann M, Glatting G (2013)
Molecular radiotherapy: the NUKFIT software for calculating the time-integrated activity coefficient.
Med Phys 40(10):102504.

Koehler C, Ginzkey C, Kleinsasser NH, Hagen R, Reiners C, Verburg FA (2013)
Short-term severe thyroid hormone deficiency does not influence sleep parameters.
Sleep Breath 17(1):253-8.

Kossert K, Jörg G, Gostomski CL (2013)
Experimental half-life determination of ¹⁷⁶Lu.
Appl Radiat Isot 81:140-5.

Kreissl MC, Schirbel A, Fassnacht M, Haenscheid H, Verburg FA, Bock S, Saeger W, Knoedler P, Reiners C, Buck AK, Allolio B, Hahner S (2013)
[¹²³I]Iodometomidate imaging in adrenocortical carcinoma.
J Clin Endocrinol Metab 98(7):2755-64.

Lassmann M, Nosske D (2013)
Dosimetry of 223Ra-chloride: dose to normal organs and tissues. Dosimetry of 223Ra-chloride: dose to normal organs and tissues.
Eur J Nucl Med Mol Imaging 40(2):207-12.

Li X, Bauer W, Kreissl MC, Weirather J, Bauer E, Israel I, Richter D, Riehl G, Buck A, Samnick S (2013)
Specific somatostatin receptor II expression in arterial plaque: (68)Ga-DOTATATE autoradiographic, immunohistochemical and flow cytometric studies in apoE-deficient mice.
Atherosclerosis 230(1):33-9.

Lonsdale MN, Lassmann M (2013)
EANM perspective.
Radiat Prot Dosimetry 153(2):166-9.

Lückerath K, Lapa C, Spahmann A, Jörg G, Samnick S, Rosenwald A, Einsele H, Knop S, Buck AK (2013)
Targeting paraprotein biosynthesis for non-invasive characterization of myeloma biology.
PLoS ONE(8):12-e84840.

Othman EM, Kreissl MC, Kaiser FR, Arias-Loza PA, Stopper H (2013)
Insulin-mediated oxidative stress and DNA damage in LLC-PK1 pig kidney cell line, female rat primary kidney cells, and male ZDF rat kidneys in vivo.
Endocrinology 154(4):1434-43.

Preylowski V, Schlögl S, Schoenahl F, Jörg G, Samnick S, Buck AK, Lassmann M (2013)

Reiners C, Biko J, Haenscheid H, Hebestreit H, Kirinjuk S, Baranowski O, Marlowe RJ, Demidchik E, Drozd V, Demidchik Y (2013)
Twenty-five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma.
J Clin Endocrinol Metab 98(7):3039-48.

Reiners C, Schneider R (2013)
Potassium iodide (KI) to block the thyroid from exposure to I-131: current questions and answers to be discussed.
Radiat Environ Biophys 52(2):189-93.

Rendl S, Lapa C, Blümel C, Bundschuh RA, Schneider P (2013)
Decision making for osteoporotic treatment using FRAX or DVO risk algorithms in a clinical setting.
J Musculoskelet Neuronal Interact 13(3):339-45.

Rischpler C, Fukushima K, Isoda T, Javadi MS, Dannals RF, Abraham R, Wahl R, Bengel FM, Higuchi T (2013)
Discrepant uptake of the radiolabeled norepinephrine analogues hydroxyephedrine (HED) and metaiodobenzylguanidine (MIBG) in rat hearts.
Eur J Nucl Med Mol Imaging 40(7):1077-83.

Verburg FA, Hartmann D, Grelle I, Giovanella L, Buck AK, Reiners C (2013)
Relationship between antithyroglobulin autoantibodies and thyroglobulin recovery rates using different thyroglobulin concentrations in the recovery buffer.

Verburg FA, Mäder U, Tanase K, Thies ED, Diessl S, Buck AK, Luster M, Reiners C (2013)
Life expectancy is reduced in differentiated thyroid cancer patients >= 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients.
J Clin Endocrinol Metab 98(1):172-80.

Verburg FA, Reiners C, Grelle I, Barth H, Fassnacht M, Luster M (2013)
Calcium stimulated calcitonin measurement: a procedural proposal.
Exp Clin Endocrinol Diabetes 121(5):318-20.

Verburg FA, Reiners C, Hänscheid H (2013)
Approach to the patient: role of dosimetric RAI Rx in children with DTC.
J Clin Endocrinol Metab 98(10):3912-9.

Verburg FA, Sweeney R, Hänscheid H, Dießl S, Israel I, Löhr M, Vince GH, Flentje M, Reiners C, Samnick S (2013)
Patients with recurrent glioblastoma multiforme. Initial experience with p-[(131)I]iodo-L-phenylalanine and external beam radiation therapy.
Nuklearmedizin 52(1):36-42.

Publikationen 2012

Angheloiu GO, Hänscheid H, Wen X, Capponi V, Anderson WD, Kellum JA (2012)
Experimental first-pass method for testing and comparing sorbent polymers used in the clearance of iodine contrast materials.
Blood Purif 34(1):34-9.

Bundschuh RA, Andratschke N, Dinges J, Duma MN, Astner ST, Brügel M, Ziegler SI, Molls M, Schwaiger M, Essler M (2012)
Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases.
Strahlenther Onkol 188(7):592-8.

Chen DY, Schneider PF, Zhang XS, He ZM, Chen TH (2012)
Fatality after cardiac arrest in thyrotoxic periodic paralysis due to profound hypokalemia resulting from intravenous glucose administration and inadequate potassium replacement.
Thyroid 22(9):969-72.

Chen DY, Schneider PF, Zhang XS, He ZM, Jing J, Chen TH (2012)
Mental health status and factors that influence the course of Graves' disease and antithyroid treatments.
Exp Clin Endocrinol Diabetes 120(9):524-8.

Chiesa C, Luster M, Lassmann M (2012)
4th international symposium on targeted radiotherapy and dosimetry (ISTARD): best ranked abstract publication.
Q J Nucl Med Mol Imaging 56(6):485-6.

Diessl S, Holzberger B, Mäder U, Grelle I, Smit JW, Buck AK, Reiners C, Verburg FA. (2012) Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 76(4):586-92.

Giovanella L, Ceriani L, De Palma D, Suriano S, Castellani M, Verburg FA (2012)
Relationship between serum thyroglobulin and 18FDG-PET/CT in 131I-negative differentiated thyroid carcinomas.
Head Neck 34(5):626-31.

Hahner S, Kreissl MC, Fassnacht M, Haenscheid H, Knoedler P, Lang K, Buck AK, Reiners C, Allolio B, Schirbel A (2012)
[131I]iodometomidate for targeted radionuclide therapy of advanced adrenocortical carcinoma.
J Clin Endocrinol Metab 97(3):914-22.

Hänscheid H, Sweeney RA, Flentje M, Buck AK, Löhr M, Samnick S, Kreissl M, Verburg FA (2012)
PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma.
Eur J Nucl Med Mol Imaging 39(8):1284-8.

Hempel K, Haenscheid H, Biko J, Hategan M, Kaiser F, Kreissl M, Lorenz R, Samnick S, Schirbel A, Varazashvili L, Verchenya S, Reiners C (2012)
Frequency of transferrin receptor positive reticulocytes (TF-Ret) in blood as an indicator of total-body radiation exposure: a pilot study in nuclear medicine patients.
Radiat Res 178(5):481-8.

Herrmann K, Erkan M, Dobritz M, Schuster T, Siveke JT, Beer AJ, Wester HJ, Schmid RM, Friess H, Schwaiger M, Kleeff J, Buck AK (2012)
Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours.
Eur J Nucl Med Mol Imaging   

Kreissl MC, Hänscheid H, Löhr M, Verburg FA, Schiller M, Lassmann M, Reiners C, Samnick SS, Buck AK, Flentje M, Sweeney RA (2012)
Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma.
Radiat Oncol 7:99.

Li Z, Graf N, Herrmann K, Jünger A, Aichler M, Feuchtinger A, Baumgart A, Walch A, Peschel C, Schwaiger M, Buck A, Keller U, Dechow T (2012)
FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapy.
Cancer Res 72(19):5014-24.

Morbach H, Schneider P, Schwarz T, Hofmann C, Raab P, Neubauer H, Düren C, Beer M, Girschick HJ (2012)
Comparison of magnetic resonance imaging and 99mTechnetium-labelled methylene diphosphonate bone scintigraphy in the initial assessment of chronic non-bacterial osteomyelitis of childhood and adolescents.
Clin Exp Rheumatol 30(4):578-82.

Schneider R, Schneider M, Reiners C, Schneider P (2012)
Effects of levothyroxine on bone mineral density, muscle force, and bone turnover markers: a cohort study.
J Clin Endocrinol Metab 97(11)3926-34.

Spallek L, Krille L, Reiners C, Schneider R, Yamashita S, Zeeb H (2012)
Adverse effects of iodine thyroid blocking: a systematic review.
Radiat Prot Dosimetry 150(3):267-77.

Verburg FA, Grelle I, Giovanella L, Reiners C (2012)
Evaluation of the BRAHMS KRYPTOR thyroglobulin "mini-recovery" test in thyroid healthy subjects.
Horm Metab Res 44(7):555-7.

Verburg FA, Smit JW, Grelle I, Visser TJ, Peeters RP, Reiners C. (2012) Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy.  Clin Endocrinol (Oxf) 76(4):577-81.

Zahn RK, Frey S, Jakubietz RG, Jakubietz MG, Doht S, Schneider P, Waschke J, Meffert RH (2012)
A contoured locking plate for distal fibular fractures in osteoporotic bone: a biomechanical cadaver study.
Injury 43(6):718-25.

Kontakt, Öffnungszeiten, Sprechzeiten

Öffnungszeiten der Ambulanzen

Montag bis Freitag

08:00 Uhr bis 16:00 Uhr

07:00 Uhr bis 16:00 Uhr

08:00 Uhr bis 16:00 Uhr




Poliklinik Aufnahme
+49 931 201-35100

Ute Dausacker, Katharina Deckert
+49 931 201-35001

OA PD Dr. Rudolf Werner


OA PD Dr. Rudolf Werner


+49 931 201-635000


Klinik und Poliklinik für Nuklearmedizin des Universitätsklinikums Zentrum Innere Medizin (ZIM) | Oberdürrbacher Straße 6 | Haus A4 | 97080 Würzburg | Deutschland